¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"muscular type of artery"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • ethmoidal artery
    ¹úÁýµ¿¸Æ, »ç°ñµ¿¸Æ
  • facial artery
    ¾ó±¼µ¿¸Æ, ¾È¸éµ¿¸Æ
  • feeding artery
    ¿µ¾çµ¿¸Æ
  • femoral artery
    ³Ò´Ù¸®µ¿¸Æ, ´ëÅ𵿸Æ
  • fibular artery
    Á¾¾Æ¸®µ¿¸Æ, ºñ°ñµ¿¸Æ
  • gastric artery
    À§µ¿¸Æ
  • gastroduodenal artery
    À§»ùâÀÚµ¿¸Æ, À§½ÊÀÌÁöÀ嵿¸Æ
  • genicular artery
    ¹«¸­µ¿¸Æ, ½½µ¿¸Æ
  • gluteal artery
    º¼±âµ¿¸Æ, µÐµ¿¸Æ
  • gonadal artery
    »ý½Ä»ùµ¿¸Æ
  • greater palatine artery
    Å«ÀÔõÀ嵿¸Æ, ´ë±¸°³µ¿¸Æ
  • hypophyseal artery
    ³úÇϼöüµ¿¸Æ
  • helicine artery
    ³ª¼±µ¿¸Æ
  • hepatic artery
    °£µ¿¸Æ
  • hepatic artery embolization
    °£µ¿¸Æ»öÀü¼ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • epigastric artery
    ¹èº®µ¿¸Æ
  • episcleral artery
    °ø¸·À§µ¿¸Æ
  • ethmoidal artery
    ¹úÁýµ¿¸Æ
  • external carotid artery
    ¹Ù±ù¸ñµ¿¸Æ
  • external iliac artery
    ¹Ù±ù¾ûµ¢µ¿¸Æ
  • external pudendal artery
    ¹Ù±ùÀ½ºÎµ¿¸Æ
  • facial artery
    ¾ó±¼µ¿¸Æ
  • feeding artery
    ¿µ¾çµ¿¸Æ
  • femoral artery
    ³Ò´Ù¸®µ¿¸Æ
  • fibular artery
    Á¾¾Æ¸®µ¿¸Æ, ºñ°ñµ¿¸Æ
  • gastric artery
    À§µ¿¸Æ
  • gastroduodenal artery
    À§»ùâÀÚµ¿¸Æ
  • genicular artery
    ¹«¸­µ¿¸Æ
  • gluteal artery
    º¼±âµ¿¸Æ
  • gonadal artery
    »ý½Ä»ùµ¿¸Æ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • artery of bulb of vestibule
    Áú¾î±Í¸Á¿ïµ¿¸Æ
  • artery of central sulcus
    Á߽ɰí¶ûµ¿¸Æ
  • artery of ligamentum teres of uterus
    ÀڱÿøÀδ뵿¸Æ
  • artery of lymph nodule
    ¸²ÇÁ¼ÒÀýµ¿¸Æ
  • artery of postcentral sulcus
    Á߽ɵڰí¶ûµ¿¸Æ
  • artery of precentral sulcus
    Á߽ɾհí¶ûµ¿¸Æ
  • artery of pterygoid canal
    ³¯°³°üµ¿¸Æ
  • artery of pterygoid canal
    ³¯°³±Ù°¡Áö
  • artery of red pulp
    Àû»ö¼ÓÁúµ¿¸Æ
  • artery of white pulp
    ¹é»ö¼ÓÁúµ¿¸Æ
  • artery to ductus deferens
    Á¤°üµ¿¸Æ
  • artery, auricular
    À̰³µ¿¸Æ
  • artery, cricothyroid
    À±»ó°©»óµ¿¸Æ
  • artery, cricothyroid branch of superior thyroid
    »ó°©»ó¼±µ¿¸ÆÀÇ À±»ó°©»óÁö, À§
  • artery, ethmoid
    »ç°ñµ¿¸Æ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • muscular tissue
    ±ÙÀ°Á¶Á÷
  • muscular tonic defect (amyotonia)
    ±ÙÀ°±äÀå°áÇÌ(±ÙÀ°¹«·ÂÁõ)
  • muscular traction
    ±Ù °ßÀÎ(ÐÉ̲ìÚ).
  • muscular tremor
    ±ÙÁøµ¿(ÐÉòÉÔÑ).
  • muscular triangle
    ±ÙÀ°»ï°¢
  • muscular trismus
    ±Ù¼º°³±¸Àå¾Ö(ÐÉàõËÒÏ¢ î¡äô).
  • muscular trochlea
    ±ÙÀ°µµ¸£·¡, ±ÙȰÂ÷ (ÐÉüÁó³).
  • muscular trochlea
    ±ÙÀ°µµ¸£·¡
  • muscular ventricular septum
    ±ÙÀ°¼º ½É½ÇÁß°Ý(ÐÉë¿àõãýãøñḛ́).
  • muscular venule
    ±ÙÀ°¼¼Á¤¸Æ
  • muscular work
    ±ÙÀ° ÀÛ¾÷(ÐÉë¿íÂåö).
  • muscular ³ª muscularis
    ±ÙÀ°ÀÇ, ±ÙÀÇ.
  • muscular ³ª muscularis
    ±ÙÀ°ÀÇ, ±ÙÀÇ.
  • muscular ³ª muscularis
    ±Ù(ÐÉ), ±ÙÀ°(ÐÉë¿), ~ÀÇ, ~¼º.
  • myelopathic muscular atrophy
    ô¼öº´Áõ¼º ±ÙÀ§Ãà.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • Groove for occipital artery
    µÚÅë¼öµ¿¸Æ°í¶û
    [¿¾ ¿ë¾î] Èĵε¿¸Æ±¸
  • Dorsal intersegmental artery
    µîÂʸ¶µð»çÀ̵¿¸Æ
    [¿¾ ¿ë¾î] ¹èÀý°£µ¿¸Æ
  • Artery of lymph nodule
    ¸²ÇÁ¼ÒÀýµ¿¸Æ
    [¿¾ ¿ë¾î] ÀӯļÒÀýµ¿¸Æ
  • Parietooccipital artery
    ¸¶·çµÚÅë¼ö¿±µ¿¸Æ
    [¿¾ ¿ë¾î] µÎÁ¤Èĵε¿¸Æ
  • Appendicular artery
    ¸·Ã¢ÀÚ²¿¸®µ¿¸Æ
    [¿¾ ¿ë¾î] Ãæ¼öµ¿¸Æ
  • Central artery of retina
    ¸Á¸·Á߽ɵ¿¸Æ
    [¿¾ ¿ë¾î] ¸Á¸·Á߽ɵ¿¸Æ
  • Uppermost intercostal artery
    ¸ÇÀ§°¥ºñ»çÀ̵¿¸Æ
    [¿¾ ¿ë¾î] ÃÖ»ó´Á°£µ¿¸Æ
  • Descending genicular artery
    ¹«¸­³»¸²µ¿¸Æ
    [¿¾ ¿ë¾î] ÇÏÇཽµ¿¸Æ
  • Labyrinthine artery
    ¹Ì·Îµ¿¸Æ
    [¿¾ ¿ë¾î] ¹Ì·Îµ¿¸Æ
  • External carotid artery
    ¹Ù±ù¸ñµ¿¸Æ
    [¿¾ ¿ë¾î] ¿Ü°æµ¿¸Æ
  • External iliac artery
    ¹Ù±ù¾ûµ¢µ¿¸Æ
    [¿¾ ¿ë¾î] ¿ÜÀå°ñµ¿¸Æ
  • External pudendal artery
    ¹Ù±ùÀ½ºÎµ¿¸Æ
    [¿¾ ¿ë¾î] ¿ÜÀ½ºÎµ¿¸Æ
  • Basal artery
    ¹Ù´Úµ¿¸Æ
    [¿¾ ¿ë¾î] ±âÀúµ¿¸Æ
  • Dorsal plantar artery
    ¹ßµîµ¿¸Æ
    [¿¾ ¿ë¾î] Á·¹èµ¿¸Æ
  • Umbilical artery
    ¹è²Åµ¿¸Æ
    [¿¾ ¿ë¾î] Á¦µ¿¸Æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
CSMA chronic spinal muscular atrophy
CXMD canine X-linked muscular dystrophy
DMD disease-modifying drug; Doctor of Dental Medicine; Duchenne muscular dystrophy; dystonia musculorum ...
EDMD Emery-Dreifuss muscular dystrophy
EMD electromechanical dissociation; emergency medical dispacher; emergency medical doctor; Emery-Dreifus...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
BAE Bronchial Artery Embolization
CABG CORONARY ARTERY BYPASS GRAFT
CABG CORONARY ARTERY BYPASS GRAFTING
CPAE Calf pulmonary artery endothelial
CA Carotid artery
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • dorsal intersegmental artery
    µîÂÊ ¸¶µð »çÀÌ µ¿¸Æ
  • dorsal metacarpal artery
    µîÂÊ ¼ÕÇ㸮 µ¿¸Æ
  • dorsal pancreatic artery
    µÚÀÌÀÚ µ¿¸Æ
  • dorsal plantar artery
    ¹ßµî µ¿¸Æ
  • ethmoid artery
    »ç°ñ µ¿¸Æ
  • external carotid artery
    ¹Ù±ù ¸ñµ¿¸Æ, ¿Ü°æ µ¿¸Æ
  • feeding artery
    ¿µ¾ç µ¿¸Æ
  • follicular artery
    ¿©Æ÷ µ¿¸Æ
  • hepatic artery
    °£ µ¿¸Æ
    1. ³»Àå µ¿¸ÆÀ¸·ÎºÎÅÍ ¿À¸¥ÆíÀ¸·Î ²¿ºÎ¶óÁ® °£Àå ¾ÈÀ¸·Î µé¾î°¡´Â µ¿¸Æ¸Á. 2. ±â¿ø : º¹°­ µ¿¸Æ, ºÐÁö : ¿ìÀ§µ¿¸Æ, À§½ÊÀÌÁöÀå µ¿¸Æ, °íÀ¯°£ µ¿¸Æ, ºÐÆ÷ : À§, ÃéÀå, ½ÊÀÌÁöÀå, °£, ´ã³¶, ´ë¸Á.
  • hyaloid artery
    À¯¸®Ã¼ µ¿¸Æ
  • ileal artery
    ȸÀå µ¿¸Æ
    »óÀå°£¸· µ¿¸Æ¿¡¼­ ±â¿øÇÏ¿© ºÐÁö¸¦ ³»Áö ¾Ê°í ȸÀå¿¡ ºÐÆ÷ÇÏ´Â µ¿¸Æ.
  • inferior epigastric artery
    ¾Æ·¡ ¹èº® µ¿¸Æ
    ¿ÜÀå°ñ µ¿¸Æ¿¡¼­ ±â¿øÇÏ¿© Ä¡°ñÁö, °íȯ °Å±Ù µ¿¸Æ, Àڱà ¿ø»è µ¿¸ÆÀ» ³»°í º¹º®¿¡ ºÐÆ÷ÇÏ´Â µ¿¸Æ.
  • inferior gluteal artery
    ¾Æ·¡ µÐºÎ µ¿¸Æ, ÇÏ µÐ µ¿¸Æ, ¾Æ·¡ º¼±â µ¿¸Æ
    ³»Àå°ñ µ¿¸Æ¿¡¼­ ±â¿øÇÏ¿© Á°ñ µ¿¸Æ¹Ý ȸµ¿¸ÆÀ» ³»°í µÐºÎ, ´ëÅð ¹èÃø ¸é¿¡ ºÐÆ÷ÇÏ´Â µ¿¸Æ.
  • inferior hypophyseal artery
    ¾Æ·¡ ³úÇϼöü µ¿¸Æ
    ³»°æ µ¿¸ÆÀÇ ´ë³úºÎ¿¡¼­ ³ª¿À´Â ÀÛÀº ºÐÁöÀ̸ç, Çϼöü¿¡ ºÐÆ÷ÇÑ´Ù.
  • inferior laryngeal artery
    ¾Æ·¡ ÈĵΠµ¿¸Æ, ÇÏÈĵΠµ¿¸Æ
    ±â¿øÀº Çϰ©»ó¼± µ¿¸ÆÀÌ¸ç ºÐÁö´Â ¾ø°í ºÐÆ÷´Â ÈĵÎ, ±â°ü, ½ÄµµÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
persecutory type of paranoid disorder One of the most common of the types of paranoid disorders, it involves a single theme or series of connected themes, such as being conspired against, cheated, spied on, followed, poisoned or drugged, maligned, harassed, or obstructed in the pursuit of long-term goals; small slights may be exaggerated and become the focus of a delusional system.
See: paranoia.
Compare: paranoid personality disorder.
(05 Mar 2000)
river-type fish <marine biology> Anadromous fish that rear for a year or more in rivers.
(23 Aug 1998)
Romanovsky type stain <technique> Composite histological stains including methylene blue, Azure A or B and eosin, sometimes with other stains.
Examples are Giemsa, Wright's and Leishman's stain.
(18 Nov 1997)
wild type <genetics> The naturally-occuring, normal, non-mutated version of a gene.
The original parent strain of a virus, bacteria, fruit fly, mouse, or other laboratory test organism. Often refers to how organisms are found naturally, in the wild, before mutations were induced by researchers.
(09 Oct 1997)
wild-type strain A strain found in nature or a standard strain.
See: auxotrophic strains, prototrophic strains.
(05 Mar 2000)
MPGN type i A kidney disorder which results in kidney dysfunction. Inflammation of the glomeruli result from an abnormal immune response and the deposition of antibodies within the kidney (glomerulus) ultrastructure. Membranoproliferative glomerulonephritis (MPGN) has been divided into two different types in the basis of where the antibodies are deposited in the glomerulus. MPGN type I, the more common type, deposits antibodies in the subendothelial layer of the basement membrane, whereas type II deposits antibodies in the bottom layer of the basement membrane.
Symptoms include cloudy urine (pyuria), decreased urine output, swelling and hypertension. This disorder often results in end-stage renal disease.
(27 Sep 1997)
mpgn type II A kidney disorder which results in kidney dysfunction. Inflammation of the glomeruli result from an abnormal immune response and the deposition of antibodies within the kidney (glomerulus) ultrastructure. Membranoproliferative glomerulonephritis (MPGN) has been divided into two different types in the basis of where the antibodies are deposited in the glomerulus. MPGN type I, the more common type, deposits antibodies in the subendothelial layer of the basement membrane, whereas type II deposits antibodies in the bottom layer of the basement membrane.
Symptoms include cloudy urine (pyuria), decreased urine output, swelling and hypertension. This disorder often results in end-stage renal disease.
(27 Sep 1997)
woodbury-type 1. A process in photographic printing, in which a relief pattern in gelatin, which has been hardened after certain operations, is pressed upon a plate of lead or other soft metal. An intaglio impression in thus produced, from which pictures may be directly printed, but by a slower process than in common printing.
2. A print from such a plate.
Origin: After the name of the inventor, W. Woodbury.
Source: Websters Dictionary
(01 Mar 1998)
multiple endocrine neoplasia type 1 A rare syndrome characterised by hyperplasia and/or neoplasms of the pituitary, parathyroid glands, and pancreatic islets. Hyperparathyroidism occurs in 90% of the cases and is usually the first manifestation of the syndrome. The most frequent pancreatic manifestation is gastrinoma typically leading to zollinger-ellison syndrome. The appearance of this condition has been limited to the loss of allelic heterozygosity at the 11q13 locus on the long arm of chromosome 11. Patients overall exhibit long survival times. Chemotherapy is rare and surgical management is generally dependent on the genetic expression in individual patients.
(12 Dec 1998)
multiple endocrine neoplasia type 2 <syndrome> This is a hereditary disorder in which two or more of the following glands: thyroid, adrenal or parathyroid, develop overgrowth (hyperplasia) or malignant cells (cancer). The underlying cause is genetic and a positive family history for this illness is a risk factor.
Incidence: approximately 3 in 100,000 people in the general population.
(27 Sep 1997)
multiple endocrine neoplasia type 2a A type of multiple endocrine neoplasia characterised by a virtually 100% incidence of medullary thyroid carcinoma, a 50% incidence of pheochromocytoma, and a lesser incidence of parathyroid adenomas associated with hyperparathyroidism. The condition is always transmitted through autosomal dominant inheritance. Genetic testing can identify individuals with the trait in early infancy. Treatment is usually excision of the enlarged parathyroid glands.
(12 Dec 1998)
multiple endocrine neoplasia type 2b A type of multiple endocrine neoplasia occurring as an isolated congenital presentation or as a distinct autosomal dominant disease. It is characterised by the 100% incidence of medullary thyroid carcinoma and frequent pheochromocytomas; patients seldom exhibit hyperparathyroidism. It is distinguished from men 2a by its characteristic physical appearance resulting from numerous neural defects including mucosal neuromas of the eyelids, lips, and tongue. The neural abnormalities also include widespread neurogangliomatosis of the gastrointestinal tract leading to abnormal gut motility. Treatment usually requires total thyroidectomy following evaluation for the presence of pheochromocytomas.
(12 Dec 1998)
multiple lipoprotein-type hyperlipidaemia <biochemistry> Inherited as a defective gene, this disorder is characterised by elevations in serum cholesterol and/or triglycerides. There are often multiple types of lipoproteins (LDL) elevated in one family. This condition is associated with an increased risk of cardiovascular disease.
Origin: Gr. Haima = blood
(27 Sep 1997)
contact-type dermatitis Dermatitis resembling contact dermatitis or eczema, but caused by an ingested or injected allergen, usually a drug, and with a widespread or generalised distribution.
(05 Mar 2000)
Cowdry's type A inclusion bodies Droplet-like masses of acidophilic material surrounded by clear halos within nuclei, with margination of chromatin on the nuclear membrane.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
ÅëÇÕ°Ë»ö ¿Ï·á